Drug Topics
NOVEMBER 14, 2022
Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.
Pharmacy Times
NOVEMBER 14, 2022
Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 14, 2022
Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.
Pharmaceutical Technology
NOVEMBER 14, 2022
In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus. In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
NOVEMBER 14, 2022
As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.
Pharmacy Times
NOVEMBER 14, 2022
Direct-acting antivirals have high efficacy for hepatitis C, however, patients with advanced liver scarring are at risk for the development of secondary diseases.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 14, 2022
Belantamab mafodotin-blmf is a first-in-class, anti-B-cell maturation antigen therapy indicated for adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies.
Drug Topics
NOVEMBER 14, 2022
Timing of treatment initiation is crucial for patients with cancer.
Pharmacy Times
NOVEMBER 14, 2022
The goals of therapy for atopic dermatitis include reducing symptoms of pruritis and dermatitis with disease control and prevention of flares.
pharmaphorum
NOVEMBER 14, 2022
Sanofi and Regeneron’s Dupixent is on track to become the first targeted drug in the EU to be approved for prurigo nodularis (PN), a rare and highly debilitating skin disease. The EMA’s human medicines committee (CHMP) has recommended IL-4 and IL-13 inhibitor Dupixent (dupilumab) to treat adults with moderate to severe PN, a disease which causes hard lumps to form on the skin that are so itchy they can lead patients to scratch themselves to the point of bleeding or pain.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
NOVEMBER 14, 2022
Just as winter looms and everyone heads inside to cough, sneeze, and spread germs, a shortage of a popular antibiotic has developed. The U.S. Food and Drug Administration (FDA) has assigned “currently in shortage” status to oral powder for suspension amoxicillin. In fact, as of Oct. 28, the FDA listed 23 amoxicillin products on its current drug shortages page due to increased demand for the drug. .
pharmaphorum
NOVEMBER 14, 2022
Every fraction of a degree matters. COP27 is in full swing and world leaders are contending with the fact that we will likely not meet the Paris Agreement’s 1.5°C target. The reality is that we will need to focus on limiting a temperature rise wherever possible and that every fraction of a degree has a real and major consequence on our global environment.
STAT
NOVEMBER 14, 2022
The brains of Black adults in the U.S. age more quickly than those of white and Hispanic adults, showing features linked to Alzheimer’s disease and other dementias as early as mid-life, according to a new study. The study , published Monday in JAMA Neurology, analyzed the MRI scans of nearly 1,500 participants from two racially and ethnically diverse cohorts.
Pharmacy Times
NOVEMBER 14, 2022
Pharmacists can provide their knowledge to female patients but also ensure women are adequately represented in research.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
NOVEMBER 14, 2022
Amazon Clinic will operate in 32 states and provide virtual care for more than 20 common health conditions, such as allergies, acne and hair loss.
STAT
NOVEMBER 14, 2022
Money has gushed into the biotech industry over the last couple of years, as the pandemic brought the industry onto center stage. At the same time, tech investors have rushed into the arena. Who has benefited the most?
Drug Store News
NOVEMBER 14, 2022
CVS pharmacists can assess eligible COVID-19 positive patients and prescribe oral antiviral medication at most locations.
Pharmacy Times
NOVEMBER 14, 2022
Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend.
STAT
NOVEMBER 14, 2022
Mile Bluff Medical Center is a long way from Silicon Valley. The 40-bed hospital is situated in a central Wisconsin city of 4,400 people, where caregivers are about as likely to encounter a moose as a machine learning engineer. That is, until now.
The Checkup by Singlecare
NOVEMBER 14, 2022
ADHD, or attention deficit hyperactivity disorder, is a neurological condition that interferes with many typical functions of the brain , particularly those related to planning and organization, impulsivity, focus and attention, and executive functioning. Like most other mental health conditions, ADHD is best managed with a combination of strategies that consider an individual’s overall health, daily routine, social and emotional needs, and even their personality.
STAT
NOVEMBER 14, 2022
New data indicate Moderna’s Covid bivalent booster may be more effective against currently circulating Omicron variants of the virus than its original vaccine, the company said Monday. Like data released by Pfizer and BioNTech regarding their Covid vaccine , the new data involves lab measurements of antibodies and their ability to neutralize the SARS-CoV-2 virus, not data on how well the vaccines prevent cases of symptomatic illness or severe disease.
Pharmaceutical Technology
NOVEMBER 14, 2022
The US Food and Drug Administration (FDA) has granted accelerated approval for ImmunoGen’s Elahere (mirvetuximab soravtansine-gynx) to treat adults with folate receptor alpha (FR?)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The antibody-drug conjugate (ADC) treatment is indicated for such patients who have previously received one to three systemic therapy regimens, irrespective of the usage of Avastin priorly.
PharmaVoice
NOVEMBER 14, 2022
On the surface, the Inflation Reduction Act is designed to lower drug prices, but its impact on innovation incentives could produce a landscape of new medicines that are costlier for patients.
Drug Topics
NOVEMBER 14, 2022
Confidence in vaccines is lower post-pandemic across all demographic groups.
Hospital Pharmacy Europe
NOVEMBER 14, 2022
An RCT has found that low-dose aspirin use failed to reduce fracture risk but was associated with higher risk of serious falls in the elderly. Daily low-dose aspirin (100 mg) use in healthy elderly patients failed to reduce the risk of fractures but increased the risk of a serious fall according to the findings of a randomised, placebo-controlled trial by Australian researchers.
Drug Store News
NOVEMBER 14, 2022
NielsenIQ’s VP of Total Wellness discusses the latest trends influencing how shoppers are searching for, engaging with and purchasing personal care and beauty products.
STAT
NOVEMBER 14, 2022
When Barrett Rollins walked into the bathroom of his Beacon Hill home, he was stunned to find his wife lying on the uneven tile floor covered in blood. Rollins and his wife, Jane Weeks, were physicians and researchers at Dana-Farber Cancer Institute and lived steps from some of the world’s best hospitals. But Weeks didn’t want medical help.
Pharmacy Times
NOVEMBER 14, 2022
Zilucoplan is a subcutaneous, self-administered peptide inhibitor of complement component 5.
STAT
NOVEMBER 14, 2022
Any other Monday morning, Josh Mesfin would have been in the lab, performing surgery on rats and devising new ways to help them heal from heart attacks — with the hope of one day using those same tools to help people. But the fourth-year UC San Diego bioengineering graduate student spent the day chanting and marching alongside fellow academic workers who launched a strike at 10 University of California campuses on Monday, decrying low wages that Mesfin says make instant ramen a dietary st
Drug Store News
NOVEMBER 14, 2022
Prescription drugs make up the majority (98%) of distributors' sales, split among sales of brand-name drugs (55.3%), branded specialty (33.7%), generic drugs (7.8%), generic specialty (.6%) and biosimilar products (.7%).
STAT
NOVEMBER 14, 2022
The Food and Drug Administration on Monday approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose of chemotherapy directly to cancer cells. The new drug, called Elahere, was developed by Immunogen, a biotech company based in Waltham, Mass. It’s the first new treatment option for advanced ovarian cancer to reach the U.S. market in more than seven years, and the first approval of a wholly owned medicine in Immunogen’s 41-
Drug Store News
NOVEMBER 14, 2022
Featuring signage at nearly 19,000 Dollar General stores in 47 states, the campaign reflects the Foundation’s partnership with Haleon, J&J and Perrigo.
STAT
NOVEMBER 14, 2022
Women’s and family health tech startup Maven Clinic announced Monday it has raised $90 million in a Series E funding round led by General Catalyst, raising the company’s valuation to $1.35 billion. The funding, which brought Maven’s total funding to $300 million, comes at a time when investment into health tech companies has slowed, with patients returning to their doctors’ offices and employers considering scaling back their virtual care benefits amid an economic dow
European Pharmaceutical Review
NOVEMBER 14, 2022
Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. VidPrevtyn Beta, recommended as a new recombinant, adjuvanted booster COVID-19 vaccine in adults previously vaccinated with an mRNA or adenoviral vector COVID-19 vaccine, is the seventh COVID-19 vaccine recommended for approval in the European Union (EU).
Expert insights. Personalized for you.
187 
Let's personalize your content